Vanessa E Millisor1, Jessica K Roberts1, Yilun Sun2, Li Tang2, Vinay M Daryani1, David Gregornik3, Shane J Cross3, Deborah Ward3, Jennifer L Pauley3, Alejandro Molinelli1, Rachel C Brennan4, Clinton F Stewart5. 1. Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA. 2. Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, USA. 3. Department of Pharmaceutical Services, St. Jude Children's Research Hospital, Memphis, TN, USA. 4. Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA. 5. Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA. Clinton.stewart@stjude.org.
Abstract
BACKGROUND AND OBJECTIVE: Monitoring renal function is critical in treating pediatric patients, especially when dosing nephrotoxic agents. We evaluated the validity of the bedside Schwartz and Brandt equations in pediatric oncology patients and developed new equations for estimated glomerular filtration rate (eGFR) in these patients. METHODS: A retrospective analysis was conducted comparing eGFR using the bedside Schwartz and Brandt equations to measured GFR (mGFR) from technetium-99m diethylenetriamine pentaacetic acid (99mTc-DTPA) between January 2007 and August 2013. An improved equation to estimate GFR was developed, simplified, and externally validated in a cohort of patients studied from September 2013 to June 2015. Carboplatin doses calculated from 99mTc-DTPA were compared with doses calculated by GFR-estimating equations. RESULTS: Overall, the bedside Schwartz and Brandt equations did not precisely or accurately predict measured GFR (mGFR). Using a data subset, we developed a five-covariate equation, which included height, serum creatinine, age, blood urea nitrogen (BUN), and gender, and a simplified version (two-covariates), which contained height and serum creatinine. These equations were used to estimate GFR in 2036 studies, resulting in precise and accurate predictors of mGFR values. Equations were validated in an external cohort of 570 studies; both new equations were more accurate in calculating carboplatin doses than either the bedside Schwartz or Brandt equation. CONCLUSIONS: Two new equations were developed to estimate GFR in pediatric oncology patients, both of which did a better job at estimating mGFR than published equations.
BACKGROUND AND OBJECTIVE: Monitoring renal function is critical in treating pediatric patients, especially when dosing nephrotoxic agents. We evaluated the validity of the bedside Schwartz and Brandt equations in pediatric oncology patients and developed new equations for estimated glomerular filtration rate (eGFR) in these patients. METHODS: A retrospective analysis was conducted comparing eGFR using the bedside Schwartz and Brandt equations to measured GFR (mGFR) from technetium-99m diethylenetriamine pentaacetic acid (99mTc-DTPA) between January 2007 and August 2013. An improved equation to estimate GFR was developed, simplified, and externally validated in a cohort of patients studied from September 2013 to June 2015. Carboplatin doses calculated from 99mTc-DTPA were compared with doses calculated by GFR-estimating equations. RESULTS: Overall, the bedside Schwartz and Brandt equations did not precisely or accurately predict measured GFR (mGFR). Using a data subset, we developed a five-covariate equation, which included height, serum creatinine, age, blood ureanitrogen (BUN), and gender, and a simplified version (two-covariates), which contained height and serum creatinine. These equations were used to estimate GFR in 2036 studies, resulting in precise and accurate predictors of mGFR values. Equations were validated in an external cohort of 570 studies; both new equations were more accurate in calculating carboplatin doses than either the bedside Schwartz or Brandt equation. CONCLUSIONS: Two new equations were developed to estimate GFR in pediatric oncology patients, both of which did a better job at estimating mGFR than published equations.
Authors: John R Brandt; Craig S Wong; Jeffery D Hanrahan; Clifford Qualls; Nancy McAfee; Sandra L Watkins Journal: Pediatr Nephrol Date: 2006-09-30 Impact factor: 3.714
Authors: Hester N Blufpand; Jorien Tromp; Floor C H Abbink; Birgit Stoffel-Wagner; Anneke A Bouman; Antoinette Y N Schouten-van Meeteren; Joanna A E van Wijk; Gertjan J L Kaspers; Arend Bökenkamp Journal: Pediatr Blood Cancer Date: 2011-04-01 Impact factor: 3.167
Authors: Lesley A Stevens; Josef Coresh; Christopher H Schmid; Harold I Feldman; Marc Froissart; John Kusek; Jerome Rossert; Frederick Van Lente; Robert D Bruce; Yaping Lucy Zhang; Tom Greene; Andrew S Levey Journal: Am J Kidney Dis Date: 2008-03 Impact factor: 8.860
Authors: J R Brandt; Craig Wong; D R Jones; C Qualls; N McAfee; E Brewer; S L Watkins Journal: Pediatr Hematol Oncol Date: 2003-06 Impact factor: 1.969
Authors: N M Marina; J Rodman; S J Shema; L C Bowman; E Douglass; W Furman; V M Santana; M Hudson; J Wilimas; W Meyer Journal: J Clin Oncol Date: 1993-03 Impact factor: 44.544
Authors: Hiroto Inaba; John C Panetta; Stanley B Pounds; Lei Wang; Lie Li; Fariba Navid; Sara M Federico; Eric D Eisenmann; Aksana Vasilyeva; Yong-Dong Wang; Sheila Shurtleff; Ching-Hon Pui; Tanja A Gruber; Raul C Ribeiro; Jeffrey E Rubnitz; Sharyn D Baker Journal: Clin Cancer Res Date: 2019-08-27 Impact factor: 12.531
Authors: Samuel J Reddick; Olivia Campagne; Jie Huang; Arzu Onar-Thomas; Alberto Broniscer; Amar Gajjar; Clinton F Stewart Journal: Cancer Chemother Pharmacol Date: 2019-08-07 Impact factor: 3.333
Authors: John C Panetta; Jessica K Roberts; Jie Huang; Tong Lin; Vinay M Daryani; K Elaine Harstead; Yogesh T Patel; Arzu Onar-Thomas; Olivia Campagne; Deborah A Ward; Alberto Broniscer; Giles Robinson; Amar Gajjar; Clinton F Stewart Journal: Br J Clin Pharmacol Date: 2020-01-08 Impact factor: 4.335
Authors: Elizabeth G Gibson; Olivia Campagne; Nicholas S Selvo; Amar Gajjar; Clinton F Stewart Journal: Cancer Chemother Pharmacol Date: 2021-09-29 Impact factor: 3.333
Authors: Mirjam E van de Velde; Emil den Bakker; Hester N Blufpand; Gertjan L Kaspers; Floor C H Abbink; Arjenne W A Kors; Abraham J Wilhelm; Richard J Honeywell; Godefridus J Peters; Birgit Stoffel-Wagner; Laurien M Buffart; Arend Bökenkamp Journal: Cancers (Basel) Date: 2021-11-26 Impact factor: 6.639